TEAR - TearLab Corporation

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue28,01425,15619,718
Cost of Revenue12,31812,55710,096
Gross Profit15,69612,5999,622
Operating Expenses
Research Development5,1526,9512,792
Selling General and Administrative25,45434,28430,372
Non Recurring-1,3721,372
Total Operating Expenses-44,108-
Operating Income or Loss-15,976-31,509-25,004
Income from Continuing Operations
Total Other Income/Expenses Net593031,254
Earnings Before Interest and Taxes-15,917-31,206-23,722
Interest Expense4,0032,0232,023
Income Before Tax-19,920-33,229-23,722
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-19,920-33,229-23,722
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-19,920-33,229-23,722
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-19,920-33,229-23,722